determinant for attracting pharmaceutical FDI provided that it is a part of a strong innovation system and active innovation …

support innovation and green growth within the European Union (EU). It focuses on the role of regulatory harmonisation and … spill-overs from foreign affiliates substantially enhance local innovation capabilities, particularly in green technologies …

. Adopting new production technologies and realizing synergy effects might allow cost reduction, product innovation and product … upgrading. Even if GVCs represent a rich environment for innovation activities, the extent to which knowledge is created and … heterogeneous innovation capacities for the firms involved. Differences in the forms of governance underlying buyer …